Janney Montgomery Scott’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-11,862
| Closed | -$375K | – | 2722 |
|
|
2023
Q3 | $375K | Buy |
11,862
+6,666
| +128% | +$211K | ﹤0.01% | 1984 |
|
|
2023
Q2 | $212K | Sell |
5,196
-175
| -3% | -$7.14K | ﹤0.01% | 2430 |
|
|
2023
Q1 | $200K | Buy |
+5,371
| New | +$200K | ﹤0.01% | 2288 |
|
|
2022
Q4 | – | Sell |
-12,691
| Closed | -$710K | – | 2616 |
|
|
2022
Q3 | $710K | Buy |
12,691
+704
| +6% | +$39.4K | ﹤0.01% | 1481 |
|
|
2022
Q2 | $624K | Sell |
11,987
-543
| -4% | -$28.3K | ﹤0.01% | 1483 |
|
|
2022
Q1 | $911K | Buy |
12,530
+318
| +3% | +$23.1K | ﹤0.01% | 1301 |
|
|
2021
Q4 | $1.44M | Buy |
12,212
+3,509
| +40% | +$415K | 0.01% | 1142 |
|
|
2021
Q3 | $1.17M | Sell |
8,703
-451
| -5% | -$60.5K | 0.01% | 1204 |
|
|
2021
Q2 | $1.48M | Sell |
9,154
-702
| -7% | -$114K | 0.01% | 1084 |
|
|
2021
Q1 | $791K | Buy |
9,856
+1,342
| +16% | +$108K | ﹤0.01% | 1318 |
|
|
2020
Q4 | $463K | Buy |
+8,514
| New | +$463K | ﹤0.01% | 1618 |
|
|
2019
Q3 | – | Sell |
-32,185
| Closed | -$527K | – | 2113 |
|
|
2019
Q2 | $527K | Buy |
32,185
+1,202
| +4% | +$19.7K | ﹤0.01% | 1404 |
|
|
2019
Q1 | $529K | Buy |
30,983
+1,936
| +7% | +$33.1K | ﹤0.01% | 1360 |
|
|
2018
Q4 | $396K | Sell |
29,047
-1
| -0% | -$14 | ﹤0.01% | 1418 |
|
|
2018
Q3 | $831K | Sell |
29,048
-1,725
| -6% | -$49.3K | 0.01% | 1143 |
|
|
2018
Q2 | $842K | Sell |
30,773
-238
| -0.8% | -$6.51K | 0.01% | 1077 |
|
|
2018
Q1 | $654K | Sell |
31,011
-2,442
| -7% | -$51.5K | 0.01% | 1184 |
|
|
2017
Q4 | $643K | Buy |
+33,453
| New | +$643K | 0.01% | 1179 |
|